Investments in equity securities
12 Months Ended
Dec. 31, 2018
Investments, Debt and Equity Securities [Abstract]  
Investments in equity securities
(4)

Investments in equity securities

Investments in equity securities as of December 31, 2018 and 2017 are summarized based on the primary industry of the investee in the table below (in millions).

 

     Cost Basis      Net
Unrealized
Gains
     Fair
Value
 

December 31, 2018 *

        

Banks, insurance and finance

    $ 44,332       $ 38,260       $ 82,592  

Consumer products

     38,783        22,838        61,621  

Commercial, industrial and other

     19,752        8,792        28,544  
  

 

 

    

 

 

    

 

 

 
    $  102,867       $  69,890       $  172,757  
  

 

 

    

 

 

    

 

 

 

 

*

Approximately 68% of the aggregate fair value was concentrated in five companies (American Express Company – $14.5 billion; Apple Inc. – $40.3 billion; Bank of America Corporation – $22.6 billion; The Coca-Cola Company – $18.9 billion and Wells Fargo & Company – $20.7 billion).

 

     Cost Basis      Net
 Unrealized 
Gains
     Fair
Value
 

December 31, 2017 *

        

Banks, insurance and finance

    $ 25,783       $ 55,026       $ 80,809  

Consumer products

     25,177        25,698        50,875  

Commercial, industrial and other

     23,716        15,140        38,856  
  

 

 

    

 

 

    

 

 

 
    $ 74,676       $   95,864       $   170,540  
  

 

 

    

 

 

    

 

 

 

 

*

Approximately 65% of the aggregate fair value was concentrated in five companies (American Express Company – $15.1 billion; Apple Inc. – $28.2 billion; Bank of America Corporation – $20.7 billion; The Coca-Cola Company – $18.4 billion and Wells Fargo & Company – $29.3 billion).

In 2011, we acquired 50,000 shares of 6% Non-Cumulative Perpetual Preferred Stock of Bank of America Corporation (“BAC”) with a liquidation value of $100,000 per share (“BAC Preferred”) and warrants to purchase up to 700,000,000 shares of common stock of BAC (“BAC Warrants”) at $7.142857 per share (up to $5 billion in the aggregate). On August 24, 2017, we exercised all of our BAC Warrants and acquired 700,000,000 shares of BAC common stock. We also surrendered substantially all of our BAC Preferred as payment of the $5 billion cost to exercise the BAC Warrants and acquire the BAC common stock. Our investment in BAC is included in the banks, insurance and finance category.